Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 35 Issue 2, February 2017

Yarrowia lipolytica colonies growing on YPD agar at 28 °C. Qiao et al. (p 173) improve the productivity and yield of carbohydrate-to-lipid conversion in this industrial yeast by redox engineering. Image credit: Hortensia Rico, Department of Microbiology, University of Valencia, Spain.

Editorial

Top of page ⤴

News

Top of page ⤴

Correction

Top of page ⤴

News

Top of page ⤴

Data Page

Top of page ⤴

News Feature

  • Despite last year's sharp decline in approvals, registrations of two RNA drugs offer a window into the current state and possible future of drug development. Looking forward, the sector seeks greater clarity on the new presidential administration's priorities and the impact of new healthcare legislation. Chris Morrison reports.

    • Chris Morrison
    News Feature
Top of page ⤴

Bioentrepreneur

Top of page ⤴

Correspondence

Top of page ⤴

Patents

Top of page ⤴

News & Views

Top of page ⤴

Analysis

  • The global effects of epistasis on protein and RNA function are revealed by an unsupervised model of amino acid co-conservation in evolutionary sequence variation.

    • Thomas A Hopf
    • John B Ingraham
    • Debora S Marks
    Analysis
Top of page ⤴

Article

Top of page ⤴

Letter

Top of page ⤴

Erratum

Top of page ⤴

Careers and Recruitment

Top of page ⤴

Search

Quick links